Matches in Nanopublications for { ?s ?p "[abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP178159.RAeCsT26iYVsOCbog62uZ252rf6jthOgsjfGIK0cpZvzg130_assertion description "[abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178159.RAeCsT26iYVsOCbog62uZ252rf6jthOgsjfGIK0cpZvzg130_provenance.
- assertion description "[abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP178071.RA9m7jce-UVm_DcL_ljjYe1-LsJgcr0giOM5v98SxZYGU130_assertion description "[abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178071.RA9m7jce-UVm_DcL_ljjYe1-LsJgcr0giOM5v98SxZYGU130_provenance.